the goal of this study was to develop a diabetesspecific scale of patient desire to participate in medical decision making (DPMD) and examine its internal consistency reliability, stability, and validity (content, discriminant, convergent, and construct).
METHODS
In a cross-sectional study, 65 patients with type 2 diabetes from a teaching hospital's general medical clinic were interviewed at baseline and 2 weeks later to measure their DPMD scores. Data were collected on demographic/clinical features, health value, social support, desire to make a final decision, and value of patient autonomy.
RESULTS
Of the 11 DPMD items, 2 distinct factors emerged representing desire for discussion and desire for information. The DPMD scale had high internal consistency reliability, was stable over 2 weeks and demonstrated good content validity. DPMD scale items were more correlated with each other than with health value or social support. Overall, patients who obtained diabetes education reported greater desire to participate in decisions. Younger patients had a greater overall desire for discussion. The DPMD desire for discussion subscale correlated with patients' desire to make the final treatment decision but not with patients' value of autonomy.
CONCLUSIONS The DPMD is a brief, reliable, valid measure for assessing patient desire to participate in diabetes medical decision making.
Get full access to this article
View all access options for this article.
References
1.
1. Vinicor F. Is diabetes a public-health disorder?Diabetes Care. 1994:17:22-27.
2.
2. Harris Ml, Hadden WC, Knowler WC, Bennett P. Prevalence of diabetes and impaired glucose tolerance and plasma glucose level in US population aged 20-74 years. Diabetes. 1987:36.
3.
3. Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1983; 329:977-986.
4.
4. Goodall T. Self-management of diabetes mellitus: a critical review. Health Psychol. 1991;10:1-8.
5.
5. UK Prospective Diabetes Study Group. Tight bloodpressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
6.
6. Padgett D, Mumford E, Hynes M, Carter R. Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus. J Clin Epidemiol. 1988;41:1007-1030..
7.
7. Kravitz R. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153: 1869-1878.
8.
8. Rosenstock IM. Understanding and enhancing patient compliance with diabetic regimens. Diabetes Care. 1985;8: 610-616.
9.
9. Becker M, Janz N. The health belief model applied to understanding diabetes regimen compliance. Diabetes Educ. 1985;11:41-47.
10.
10. Peters AL, Davidson MB. Application of a diabetes managed care program. The feasibility of using nurses and a computer system to provide effective care. Diabetes Care. 1998;21:1037-1043.
11.
11. Wing R, Epstein L, Nowalk MP, Scott N, Koeske R. Compliance to self-monitoring of blood glucose: a marked-item technique compared with selfreport. Diabetes Care. 1985;8: 456-460.
12.
12. Christensen N, Terry D, Wyatt S, Pichert J, Lorenz R. Quantitative assessment of dietary adherence in patients with insulin-dependent diabetes mellitus. Diabetes Care. 1983; 6:245-250.
13.
13. Bloom J, Cerkoney KA, Hart L. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care. 1980;3:594-598.
14.
14. Johnson SB. Methodological issues in diabetes research. Measuring adherence. Diabetes Care. 1992;15:1658-1667.
15.
15. Schlenk E, Hart L. Relationship between health locus of control, health value, and social support and compliance of persons with diabetes mellitus. Diabetes Care. 1984;7:566-574.
16.
16. Toobert D, Glasgow R. Problem solving and diabetes self-care. J Behav Med. 1991; 14:71-86.
17.
17. Amir S, Rabin C, Galatzer A. Cognitive and behavioral determinants of compliance in diabetes. Health Soc Work. 1990: 144-151.
18.
18. Campbell EM, Redman S, Moffitt PS, Sanson-Fisher RW. The relative effectiveness of educational and behavioral instruction programs for patients with NIDDM: a randomized trial. Diabetes Educ. 1996;22: 379-386.
19.
19. Mazzuca S, Weinberger M, Kurpius D, Froehle T, Heister M. Clinician communication associated with diabetes patients' comprehension of their therapeutic regimen. Diabetes Care. 1983:6.
20.
20. Anderson L. Health care communication and selected psychological adherence in diabetes management. Diabetes Care. 1990;13:66-67.
21.
21. Svarstad BL. Physician-patient communication and patient conformity with medical advice. In: Mechanic D, ed. The Growth of Bureaucratic Medicine. New York: John Wiley; 1976:220-223.
22.
22. Rost K. The influence of patient participation on satisfaction and compliance. Diabetes Educ. 1989;15:134-138.
23.
23. Street R, Piziak V, Carpentier W, Herzog J, Hejl J. Provider-patient communication and metabolic control. Diabetes Care. 1993;16:714-721.
24.
24. Kaplan SM, Greenfield S, Ware J. Assessing the effects of physician-patient interaction on the outcomes of chronic disease. Med Care. 1989;27: 110-127.
25.
25. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med. 1997;127:788-795.
26.
26. Kravitz R, Cope D, Bhrany V, Leake B. Internal medicine patients' expectations for care during office visits. J Gen Intern Med. 1994;9:75-81.
27.
27. DiMatteo MR. Health professional-patient communication: the effects on health behaviors. In: Gochman DS, ed. The Handbook of Health Behavior Research. New York: Plenum Press; 1997.
28.
28. Strull W, Lo B, Charles G. Patients want to participate in medical decision making?JAMA. 1984;252:2990-2994.
29.
29. Beisecker A, Beisecker TD. Patient information-seeking behaviors when communicating with doctors. Med Care. 1990; 28:19-28.
30.
30. Blanchard C. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med. 1988;27:1139-1145.
31.
31. Cassileth B. Information and participation preferences among cancer patients. Ann Intern Med. 1980;92:832-836.
32.
32. Ende J, Kazis L, Ash A, Moskowitz M. Measuring patients' desire for autonomy: decision making and informationseeking preferences among medical patients. J Gen Intern Med. 1989;4:24-30.
33.
33. Ende J, Kazis L, Moskowitz M. Preferences for autonomy when patients are physicians. J Gen Intern Med. 1990;5: 506-509.
34.
34. Bradley JG, Zia MJ, Hamilton N. Patient preferences for control in medical decision making: a scenario-based approach. Fam Med. 1996;28: 496-501.
35.
35. Degner LF, Kristjanson U, Bowman D, et al. Informational needs and decisional preferences in women with breast cancer. JAMA. 1997;277: 1485-1492.
36.
36. Pendelton L, House W. Preferences for treatment approaches in medical care. Med Care. 1984;22:644-646.
37.
37. Ruzicki D. Relationship of participation preference and health locus of control in diabetes education. Diabetes Care. 1984;7:372-377.
38.
38. Anderson LA, DeVellis RF, Boyles BF, Feussner JR. Patients' perceptions of their clinical interactions: development of the multidimensional desire for control scales. Health Educ Res. 1989;4:383-397.
39.
39. Golin CG, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit: implication for adherence to diabetes care. Diabetes Care. 1996;19:1153-1164.
40.
40. Linder Pelz SU. Toward a theory of patient satisfaction. Soc Sci Med. 1982;16: 577-582.
41.
41. Francis VK, Korsch B, Morris M. Gaps in doctor-patient communication: patients' response to medical advice. N Eng J Med. 1969;280: 535-540.
42.
42. Anderson RM, Funnell MM, Barr PA, Dedrick RF, Davis WK. Learning to empower patients: results of professional education program for diabetes educators. Diabetes Care. 1991;14:584-590.
43.
43. McBride CA, Shugars DA, DiMatteo MR, Lepper HS, O'Neil EH, Damush TM. The physician's role. Views of the public and the profession on seven aspects of patient care. Arch Fam Med. 1994;3: 948-953.
44.
44. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705-714.
45.
45. Kane J, Lawler III E. Methods of peer assessent. Psychological Bull. 1978;85: 555-586.
46.
46. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
47.
47. Klein R, Klein BE. Relation of glycemic control to diabetic compliactions and health outcomes. Diabetes Care. 1998; 21(suppl 3):C39-C43.
48.
48. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetes Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105:1801-1815.
49.
49. Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. JAMA. 1997; 278:1662-1669.
50.
50.Testa MA, Simonson DC, Turner RR. Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care. 1998; 21(suppl 3):C44-C52.
